DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients
DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients
复制标题
DOI:
10.1016/j.diabet.2009.05.007
复制
发表时间:
2010-02-01
影响因子:
7.2
通讯作者:
Kabir, Y.
中科院分区:
文献类型:
--
作者:
Arif, M.;Islam, M. R.;Kabir, Y.
Background and aim.- Diabctes mellitus is a complex Metabolic disorder characterized by a distrubance ill glucose metabolism I is Ill Recent evidence Back suggest that increased oxidative stress as well as alteration of oxidative capacity may be related to the Complications seen in patients, with type 2 diabetes. The aim Of this study, Was 10 measure serum antioxidant status in type 2 diabetic patients and to assess its relationship with oxidative DNA damage.Methods. - A total of 57 subjects were included in this study. Of these, 32 were type 2 diabetic patients and 25 were non-diabetic subjects. Comet assay was used to quantify level of DNA change in lymphocytes. Spectroscopy Methods were used to assess of serum levels Of malondialdehyde (MDA) and protein carbonyl, and serum activity of superoxide dismutase (SOD) and the protein thiol (P-SH)Results. - A significant increase in mean Comet tail DNA, indicating DNA change. was observed in diabetic patients Compared with Controls. Diatietic patients had significanfly higher levels of MDA and protein carbonyl in parallel with significant decreases in levels of SOD and the P-SH group Compared With controls. Serum SOD was also inversely Correlated with the increase in Comet tail DNA.Conclusion. -These results indicate the presence of specific lipid peroxidation, protein Oxidation and oxidative DNA changes in patients with diabetes. Perturbation Of glucose homoeostasis was associated with an increase in oxidants and,I concomitant decrease of antioxidant enzymes in the type 2 diabetic patients' blood. The present study suggests that the status of oxidant-antioxidant imbalance may be one of the mechanisms leading to the DNA damage detected in the lymphocytes of type2-diabetic patients. (C) 2009 Published by Elsevier Masson SAS.